Table 2.
Groups | |||
---|---|---|---|
Variables | All N = 200 |
Men N = 158 |
Women N = 42 |
Age, years, mean ± SD | 65.5 ± 9.8 | 64.7 ± 9.5 | 68.2 ± 10.2 |
Social factors | |||
Born in Swedena n = 199 (%) | 158 (79.3) | 123 (77.8) | 35 (83.3) |
Higher educationa n = 200 (%) | 47 (23.5) | 35 (22.2) | 12 (28.6) |
Currently workinga n = 199 (%) | 72 (34.4) | 62 (39.2) | 10 (23.8) |
Smokinga n = 200 | |||
Never (%) | 62 (31.0) | 45 (28.5) | 17 (40.5) |
Regularly (%) | 13 (6.5) | 13 (8.2) | 0 (0.0) |
Sometimes (%) | 12 (6.0) | 11 (7.0) | 1 (2.4) |
Quit (%) | 113 (56.5) | 89 (56.3) | 24 (57.1) |
Exercisea n = 200 | |||
Sedentary n (%) | 28 (14) | 18 (11.4) | 10 (23.8) |
Moderate activity n (%) | 81 (40.5) | 63 (39.9) | 18 (42.9) |
Regular activity n, (%) | 50 (25.5) | 41 (35.9) | 9 (21.4) |
Vigorous activity n, (%) | 41 (20.5) | 36 (22.8) | 5 (11.9) |
Cardiovascular diseases | |||
Atrial fibrillationa n = 196 (%) | 29 (14.8) | 19 (12.3) | 10 (24.4) |
Known heart failurea n = 193 (%) | 16 (8.3) | 10 (6.5) | 6 (15.8) |
Hypertensiona n = 194 (%) | 123 (63.4) | 93 (61.2) | 30 (71.4) |
Diabetesa n = 197 (%) | 43 (21.8) | 37 (23.6) | 6 (15) |
Stroke/TIAa n = 198 (%) | 14 (7.2) | 12 (7.7) | 2 (4.9) |
Hyperlipidemiaa n = 180 (%) | 115 (63.9) | 90 (63.4) | 25 (65.8) |
Previous MI n = 200 (%) | 26 (13.0) | 19 (12.0) | 8 (19.0) |
Previous PCI n = 200 (%) | 23 (11.5) | 18 (11.4) | 5 (11.9) |
Non-cardiovascular disease | |||
Cancera n = 200 (%) | 31 (15.5) | 22 (13.9) | 9 (21.4) |
COPD n = 193 (%) | 39 (20.2) | 29 (19.1) | 10 (24.4) |
OSA n = 162 (%) | 48 (29.6) | 37 (29.6) | 11 (29.7) |
Renal failure GFR < 60 n = 200 (%) | 55 (27.5) | 33 (20.1) | 18 (42.9) |
Renal failure GFR < 30 n = 200 (%) | 4 (2) | 4 (2.5) | 0 (0.0) |
Depressed for at least 2 consecutive weeks in the past 12 monthsa n = 200 (%) | 30 (15) | 20 (12.7) | 10 (23.8) |
Data were presented as n (%)
TIA transient ischemic attack, MI myocardial infarction, PCI percutaneous coronary intervention, COPD chronic obstructive pulmonary disease, OSA obstructive sleep apnea
aSelf-specified answers to questions in the SEPAT questionnaire